Summary:

- The article discusses the potential use of nanoparticles in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
- The researchers reviewed the current literature on the application of nanoparticles in the delivery of therapeutic agents to the brain, highlighting their ability to cross the blood-brain barrier and target specific pathological mechanisms.
- The article emphasizes the need for further research and development to optimize the design and safety of nanoparticle-based therapies for neurodegenerative disorders, which could lead to more effective and targeted treatments.